Kanagawa, Japan

Takashi Nakahata

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.9

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Takashi Nakahata: Innovator in Cardiac Disease Treatment

Introduction

Takashi Nakahata is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cardiac diseases. With a total of 4 patents to his name, Nakahata's work is paving the way for innovative treatments in cardiology.

Latest Patents

Nakahata's latest patents include groundbreaking compounds that act as CaMKII inhibitors. One of his notable inventions is a fused heteroaryl compound that is expected to be useful in the prophylaxis or treatment of various cardiac conditions, including catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, and fatal arrhythmia. This compound is represented by a specific formula, with each symbol defined in the patent description. Another significant patent involves substituted amines that also target cardiac diseases, providing similar therapeutic benefits.

Career Highlights

Currently, Takashi Nakahata is associated with Cardurion Pharmaceuticals, LLC, where he continues to focus on innovative solutions for cardiac health. His expertise in the field has led to the development of several important compounds that hold promise for improving patient outcomes.

Collaborations

Nakahata has collaborated with notable colleagues, including Nobuyuki Matsunaga and Yasufumi Miyamoto. These partnerships have enhanced the research and development efforts within the pharmaceutical domain.

Conclusion

In summary, Takashi Nakahata is a key figure in the innovation of treatments for cardiac diseases. His patents and ongoing work at Cardurion Pharmaceuticals highlight his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…